ACCURAY INCORPORATED

ARAY ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $401.9M $458.5M $446.6M $447.6M $429.9M $396.3M $382.9M $418.8M
Cost of Revenue $290.5M $311.5M $303.6M $293.6M $270.0M $236.8M $233.2M $256.1M
Gross Profit $111.5M $147.0M $142.9M $154.0M $160.0M $159.5M $149.7M $162.7M
Gross Margin 27.7% 32.1% 32.0% 34.4% 37.2% 40.3% 39.1% 38.8%
Operating Expenses
Research & Development $37.8M $47.9M $49.7M $57.1M $57.8M $52.7M $49.8M $56.5M
SG&A Expense $45.4M $47.9M $50.1M $48.3M $44.4M $41.7M $40.1M $49.6M
Operating Income $-26.4M $7.8M $504.0K $2.4M $8.1M $22.2M $12.5M $583.0K
Operating Margin -6.6% 1.7% 0.1% 0.5% 1.9% 5.6% 3.3% 0.1%
Interest Expense $32.1M $13.0M $11.6M $10.6M $8.1M $16.9M $18.1M $15.1M
Pretax Income $-47.2M $1.1M $-11.8M $-6.8M $-2.0M $-4.6M $5.7M $-14.3M
Income Tax Expense $1.9M $2.7M $3.7M $2.5M $3.3M $1.8M $1.9M $2.1M
Net Income $-49.2M $-1.6M $-15.5M $-9.3M $-5.3M $-6.3M $3.8M $-16.4M
Net Margin -12.2% -0.3% -3.5% -2.1% -1.2% -1.6% 1.0% -3.9%
EPS (Basic) $-0.40 $-0.02 $-0.16 $-0.10 $-0.06 $-0.07 $0.04 $-0.19
EPS (Diluted) $-0.02 $-0.16 $-0.10 $-0.06 $-0.07 $0.04 $-0.19
Shares Outstanding (Basic) 122.6M 102.8M 98.3M 94.9M 92.1M 92.0M 89.9M 87.5M
Shares Outstanding (Diluted) 122.6M 102.8M 98.3M 94.9M 92.1M 92.0M 90.6M 87.5M
Dividends Per Share
← Newer Page 1 of 3 Older →